CompoAtlas

Vitamin B12 1200 mcg Extended Release Tablet

Natural health product licensed in Canada

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Vitamine B12

Source : Cyanocobalamine

1,200 mcgNot calculated

Non-medicinal ingredients

Dioxyde de titane, Talc, Phosphate dicalcique, Stéarate de magnésium, Dioxyde de silicium, Rouge allura AC, Laque d'aluminium - carmin d'indigo, Poly(éthylène glycol), Hypromellose, Poly(alcool vinylique), Cire de Carnauba

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Comprimé1 Tous les jours

Uses authorised in Canada

A factor in the maintenance of good health. Contributes to maintaining general health. For maintaining general health. Helps in energy metabolism in the body. Helps in the normal function of the immune system. Helps to form red blood cells. Helps to maintain healthy metabolism. Helps to maintain the body's ability to metabolize nutrients. Helps to prevent vitamin B12 deficiency. Helps to prevent vitamin B12 deficiency and to form red blood cells. Maintains good health. Supports good health. Vitamin supplement.Source of vitamin B12, a factor in normal growth and development. Source of vitamin B12, a factor in the maintenance of good health. Source of vitamin B12 to support biological functions which play a key role in the maintenance of good health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Product record

Licence holder
Wampole Group L.P.
NPN or DIN-HM
80105487
Status
Active licence
Licence date
20 October 2020
Revision date
Not provided
Form
Comprimé, enrobé par pellicule, libération prolongée
Route of administration
Orale
Application type
Générale (non traditionelle)

Source

Official Health Canada record, licence 80105487

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Vitamin B12 1200 mcg Extended Release Tablet”, https://compoatlas.com/en/supplements/canada/80105487-vitamin-b12-1200-mcg-extended-release-tablet, updated 20 October 2020.

Enter to analyse, Shift+Enter for a new line